Simplex Trading’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,423
Closed -$82.9K 8423
2024
Q3
$114K Buy
+3,423
New +$117K ﹤0.01% 5092
2024
Q2
Sell
-100
Closed -$2K 8699
2024
Q1
$2K Buy
+100
New +$2.37K ﹤0.01% 8351
2023
Q1
Sell
-29
Closed 8929
2022
Q4
$0 Buy
+29
New +$819 ﹤0.01% 9122
2022
Q1
Sell
-85
Closed -$2.57K 10297
2021
Q4
$2K Sell
85
-558
-87% -$17.7K ﹤0.01% 9950
2021
Q3
$16K Hold
643
﹤0.01% 8599
2021
Q2
$16K Sell
643
-14,802
-96% -$355K ﹤0.01% 8754
2021
Q1
$332K Buy
15,445
+8,723
+130% +$220K ﹤0.01% 4014
2020
Q4
$144K Buy
+6,722
New +$163K ﹤0.01% 5030
2020
Q3
Sell
-1,075
Closed -$19.4K 7720
2020
Q2
$24K Buy
+1,075
New +$19.7K ﹤0.01% 6065
2019
Q2
Sell
-30
Closed -$2.16K 7029
2019
Q1
$2K Sell
30
-64
-68% -$4.42K ﹤0.01% 6751
2018
Q4
$5K Buy
+94
New +$6.99K ﹤0.01% 6189
2018
Q3
Sell
-166
Closed -$13.8K 7340
2018
Q2
$11K Sell
166
-438
-73% -$36.7K ﹤0.01% 6269
2018
Q1
$62K Buy
+604
New +$68.1K ﹤0.01% 2214

Other funds holding ANAB

Simplex Trading's ANAB Position: Q4 2024 in Review

Simplex Trading sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 3,423 shares — an estimated $82.9K sold.

Simplex Trading first reported a position in ANAB in Q1 2018 and held it in 13 quarters. The position peaked at $332K in Q1 2021. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

  • Simplex Trading reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 3,423 AnaptysBio shares in Q4 2024, an estimated $82.9K.
  • Simplex Trading first reported a position in AnaptysBio in Q1 2018 and held it in 13 quarters.
  • Simplex Trading's AnaptysBio position peaked at $332K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.